Nw. Guldner et al., Clenbuterol-supported dynamic training of skeletal muscle ventricles against systemic load - A key for powerful circulatory assist?, CIRCULATION, 101(18), 2000, pp. 2213-2219
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-The profound loss of power that occurs in skeletal muscle after
electrical conditioning has been the major limiting factor in its clinical
application. This study investigates a 3-fold approach for chronic conditio
ning of skeletal muscle ventricles (SMVs) combining electrical transformati
on, dynamic training against systemic load, and pharmacological support wit
h clenbuterol,
Methods and Results-In 10 adult male goats, SMVs were constructed from lati
ssimus dorsi muscle wrapped around an intrathoracic training device with wi
ndkessel characteristics. SMVs were stimulated electrically and trained dyn
amically by shifting volume against systemic load. Group 1 goats were contr
ols (n=5), and group 2 goats (n=5) were supported with clenbuterol (150 mu
g 3 times a week). SMV dynamics were recorded weekly over 5 to 8 months: pe
ak pressure (P-max), stroke volume (SV), volume displacement per minute (VD
), stroke work per day (SW/d), and maximum rates of pressure generation, +d
P/dt(max), and decay, -dP/df(max). In group 1, after 149.5 +/- 27 days (n=4
), data were P-max = 70.8 +/- 4.7 mm Hg, SV=3.2 +/- 1.2 mt, VD=62.3 +/- 21.
1 mL/min, SW/d=0.8 +/- 0.4 kJ, dP/dt(max)= 64 +/- 13 mm Hg/s, and -dP/dt(ma
x) = 156 +/- 32 mm Hg/s. These parameters were significantly improved (P<0.
007) in the clenbuterol-treated group 2 after 151 +/- 2.7 days: P-max=176.2
+/- 43.8 mmHg, SV=23.3 +/- 6.1 mt, VD=568.2 +/- 186.1 mL/min, SW/d=9.1 +/-
2.2 kJ, +dP/dt(max)=1134 +/- 267 mm Hg/s, and -dP/dt(max)=1028 +/- 92 mm H
g/s. In 2 SMVs of group 2, VD increased to 1090 and 1235 mL/min after 202 a
nd 246 days of training, respectively. At termination, myosin heavy chains
were totally transformed into myosin heavy chain-1 in all SMVs.
Conclusions-This clenbuterol-supported dynamic training provides powerful S
MVs that may have important clinical implications for the treatment of end-
stage heart failure by muscular blood pumps.